Retinal Telangiectasis: Clinical Trials

3 trials for Retinal Telangiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Retinal Telangiectasis: new trials by email Literature Review of Retinal Telangiectasis trials Research Report on Retinal Telangiectasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)
THR-317 8mg - Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia
Phase 2CompletedThromboGenics82018-09-182020-09-02
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
ranibizumab injection (0.5 mg) - Coats' Disease, Idiopathic Retinal Telangiectasia
Phase 1 / Phase 2CompletedManhattan Eye, Ear & Throat Hospital182007-05-012012-10-25
Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
anecortave acetate - Coat's Disease
Phase 2CompletedManhattan Eye, Ear & Throat Hospital42002-03-012012-10-24

Narrower conditions

Idiopathic Juxtafoveal Retinal Telangiectasia (1)  ·  Myopia, Degenerative (1)  ·  Polypoidal Choroidal Vasculopathy (1)  ·  Pseudoxanthoma Elasticum (1)  ·  Vitelliform Macular Dystrophy (1)  ·  von Hippel-Lindau Disease (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Eye Diseases (3)  ·  Retinal Diseases (3)  ·  Telangiectasis (3)  ·  Vascular Diseases (3)  ·  Abnormalities, Multiple (1)  ·  Angiomatosis (1)  ·  Choroid Diseases (1)  ·  Choroidal Neovascularization (1)  ·  Ciliopathies (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Ranibizumab (1)  ·  TB-403 (1)  ·  anecortave acetate (1)

Sponsors

Manhattan Eye, Ear & Throat Hospital (2)  ·  ThromboGenics (1)

Countries

United States (2)  ·  France (1)  ·  Switzerland (1)

Top investigators

Lawrence A. Yannuzzi, MD (2)

NIH funding

2017 (1)